Department of Internal Medicine - Division of Immunology

Reference Bibliography
for Rotating Residents and Medical Students

Antiphospholipid Antibody Syndrome

Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006 Mar 1;295(9):1050-7.

Levine JS. The antiphospholipid syndrome. N Engl J Med. 2002 Mar 7;346(10):752-63

Amyloidosis

Buxbaum JN. The systemic amyloidoses. Curr Opin Rheumatol. 2004 Jan;16(1):67-75.

Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006 Sep 25;166(17):1805-13.

Nakamura T. Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis. Mod Rheumatol. 2008;18(2):109-18.

Basics of the Musculoskeletal System

Section I. Structure and Function of Bone, Joints and Connective Tissue. Harris: Kelley’s Textbook of Rheumatology, 7th Ed. [available via MDConsult on Hardin Website]

Crystal Arthritis

Keith MP, Gilliland WR. Updates in the management of gout. Am J Med. 2007 Mar; 120 (3):221-4.

Underwood M. Diagnosis and management of gout. BMJ. 2006 June 3:332(7553): 1315-9.

Choi HK, et al. Pathogenesis of gout. Ann Intern Med. 2005 Oct 4;143(7):499-516.

Rosenthal AK. Update in calcium deposition diseases. Curr Opin Rheumatol. 2007 Mar;19(2):158-62.

Disability

Taiwo OA, Cantley L. Impairment and disability evaluation: the role of the family physician. Am Fam Physician. 2008 Jun 15;77(12):1689-94

Fibromyalgia

Abeles AM, et al. Narrative review: the pathophysiology of fibromylagia. Ann Intern Med. 2007 May 15;146(10):726-34.

Clauw DJ. Pharmacotherapy for patients with fibromyalgia. J Clin Psychiatry. 2008;69 Suppl 2:25-9.

Clauw DJ. Fibromyalgia: update on mechanisms and management. J Clin Rheumatol. 2007 Apr: 13 (2): 102-9.

HIV Infection: Rheumatic Manifestations

Louthrenoo W. Rheumatic manifestation of human immunodeficiency virus infection. Curr Opin Rheumatol. 2008 Jan;20(1):92-9.

Walker UA, Tyndall A, Daikeler T. Rheumatic conditions in human immunodeficiency virus infection. Rheumatology (Oxford). 2008 Jul;47(7):952-9.

Infectious Arthritis

Mathews CJ, Coakley G. Septic arthritis: current diagnostic and therapeutic algorithm. Curr Opin Rheumatol. 2008 Jul;20(4):457-62.

Kherani RB, Shojania K. Septic arthritis in patients with pre-existing inflammatory arthritis. CMAJ. 2007 May 22;176(11):1605-8.

Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infection. N Engl J Med. 2004 Oct 14;351(16):1645-54.

Joint Replacement

Lane NE. Clinical practice. Osteoarthritis of the hip. N Engl J Med. 2007 Oct 4;357(14):1413-21.

Fortin PR, Penrod JR, Clarke AE, et al. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum 2002;46:3327-30.

Harris WH, Sledge CB. Total hip and total knee replacement. N Engl J Med. 1990; 323:725-731. [not available online]

Laboratory Tests

A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev. 2007 Nov;7(1):77-84.

Nishimura K, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007 Jun 5;146(11):797-808.

Ward, Michael. Relative sensitivity to change of the Erythrocyte Sedimentation Rate and Serum C-Reactive Protein Concentration in Rheumatoid Arthritis. J Rheumatol. 2003;31:884-95.

Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet. 2006 Jul 29;368(9533):404-18.

Lyme Disease

Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med. 2006 Jun 29;354(26):2794-801.

Feder HM Jr, et al. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. Clin Dermatol. 2006 Nov-Dec;24(6):509-20.

Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA 2007 Jun 20;297(23):2617-27.

Medications

Jones R, et al. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Med. 2008 Jun;121(6):464-74.

Bjordal JM, et al. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ. 2004 Dec 4;329(7478):1317.

Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006 Mar;65(3):285-93.

Van Everdingen AA, Jacobs Jw, Siewertsz van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002;136:1-12.

American College of Rheumatology Position Statement. Screening for Hydroxychloroquine Retinopathy. 02/22/06. http://www.rheumatology.org/publications/position/hydroxyp.asp?aud=mem

Matteson E, Weyand C, Fulbright J, et al. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to ‘non-aggressive DMARD treatment and perspective from a 2-yr open label trial. Rheumatology 2004;43:619-625.

Donahue KE, et al. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med. 2008 Jan 15;148(2):124-34.

Kremer JM. Toward a better understanding of methotrexate. Arthritis Rheum. 2004 May; 50(5):1370-82.

Bongartz T, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006 May 17;295(19):2275-85.

Reynolds J, et al. Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis. Pharmacotherapy. 2007 Dec; 27(12):1693-701.

Petrella RJ, Petrella M. A prospective, randomized, double-blind placebo controlled study the evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006 May;33(5):951-6.

Moore Ra, Derry S. Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis. Arthritis Res Ther. 2006;8(6):R182.

Chaudhuri K, Torley H, Madhok R. Disease-modifying anti-rheumatic drugs. Cyclosporine. Br J Rheumatol. 1997 Sep;36(9):1016-21.

Schlesinger N, Schumacher R, Catton M, Maxwell L. Colchicine for acute gout. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006090.

Strand V. et al. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years. Rheumatology (Oxford). 2006 Dec;45(12):1505-13.

O’Dell JR, et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002 May;46(5):1164-70.

Saag KG, Teng GG, Patkar NM, Anuntiyo J, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008 Jun 15;59(6):762-84.

Ginzler EM, et al. Mycophenalate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005 Nov 24;353(21):2219-28.

Rau R, Herborn G, Menninger H, Sangha O. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a 1-year double-blind study in 174 patients. Rheumatology (Oxford). 2002 Feb;41(2):196-204.

Miscellaneous

Gayed M, Gordon C. Pregnancy and rheumatic diseases. Rheumatology (Oxford). 2007 Nov;46(11):1634-40.

Boin F, Wigley FM. Understanding, assessing and treating Raynaud’s phenomenon. Curr Opin Rheumatol. 2005 Nov;17(6):752-60.

Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know?
Rheumatology (Oxford). 2004 Aug;43(8):949-54.

Rho R, et al. Complex Regional Pain Syndrome. Mayo Clin Proc. 2002;77:174-180.

Van Leuven SI. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford). 2008 Jan;47(1):3-7.

Myositis

Engel WK, Askanas V. Inclusion-body myositis: clinical, diagnostic and pathologic aspects. Neurology. 2006 Jan 24;66(2 Suppl 1):S20-9.

Klopstock T. Drug-induced myopathies. Curr Opin Neurol. 2008 Oct;21(5):590-5

Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003 Sep 20;362(9388):971-82.

Choy EH, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford). 2002 Jan;41(1):7-13.

Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol. 2006 Sep-Oct;24(5):363-73.

Osteoarthritis

Lane NE. Clinical practice. Osteoarthritis of the hip. N Engl J Med. 2007 Oct 4;357(14):1413-21.

Hunter DJ. In the clinic. Osteoarthritis. Ann Intern Med. 2007 Aug 7;147(3):ITC8-1-ITC8-16.

Kirkley A, et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2008 Sep 11;359(11):1097-107.

Herrero-Beaumont G. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007 Feb;56(2):555-67.

Sarzi-Puttini P, Atzeni F. New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis). Curr Opin Rheumatol. 2004 May;16(3):287-92.

Osteonecrosis

Hess, LM, et al. “Factors associated with osteonecrosis of the jaw among bisphosphonate users”. Am J Med. 2008 Jun;121(6):475-483.e3.

Malizos KN, et al. Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol. 2007 Jul;63(1):16-28.

Osteoporosis

Lane NE. Epidemiology, etiology and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006 Feb;194(2 Suppl):S3-11

Poole KE, Compston JE. Osteoporosis and its management. BMJ. 2006 Dec 16;333(7581):1251-6.

Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med. 2008 Apr 3;358(14):1474-82.

Wells, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001155.

Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81. Review.

Patient Education

Koehn CL, Esdaile JM. Patient education and self-management of musculoskeletal disorders. Best Pract Res Clin Rheumatol. 2008 June; 22(3):395-405.

Radiology

Ostergaard M, et al. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheumatol. 2005 Feb;19(1):91-116.

Jacobsen JA, Girish G, Jiang Y, Resnick D. Radiographic evaluation of arthritis: inflammatory conditions. Radiology. 2008 Aug;248(2):378-89.

Regional Musculoskeletal Disorders

Stephens, Mark, et al. Musculoskeletal Injections: A Review of the Evidence. Am Fam Physician. 2008 Oct 15; 78(8):971-976.

Cardone DA. Diagnostic and therapeutic injection of the hip and knee. Am Fam Physician. 2003 May 15;67(10):2147-52.

Bland JD. Carpal tunnel syndrome. BMJ. 2007 Aug 18;335(7615):343-6.

Wilson JF. In the clinic. Low back pain. Ann Intern Med. 2008 May 6;148(9):ITC5-1-ITC5-16.

Chou, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007 Oct 2;147(7):478-91.

Dias R, Cutts S, Massoud S. Frozen shoulder. BMJ. 2005 Dec 17;331(7530):1453-6.

Mitchell C, et al. Shoulder pain: diagnosis and management in primary care. BMJ. 2005 Nov 12;331(7525):1124-8

Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology (Oxford). 2006 May;45(5):508-21.

Dixit S, et al. Management of patellofemoral pain syndrome. Am Fam Physician. 2007 Jan 15;75(2):194-202.

Rheumatic Fever

Cilliers AM. Rheumatic fever and its management. BMJ. 2006 Dec 2;333(7579):1153-6.

Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005 Jul 9-15;366(9480):155-68.

Rheumatoid Arthritis

Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis. 2006 May;65(5):564-72.

Voskuyl AE. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv4-7.

Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med. 2007 Nov;120(11):936-9.

Bongartz T, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006 May 17;295(19):2275-85.

Emery P. Treatment of rheumatoid arthritis. BMJ. 2006 Jan 21;332(7534):152-5.

Paraskevas, KI. Statin treatment for rheumatoid arthritis: a promising novel indication. Clin Rheumatol. 2008 Mar;27(3):281-7.

Scleroderma

Chung L, Lin J, Furst DE, Fiorentino D. Systemic and localized scleroderma. Clin Dermatol. 2006 Sep-Oct;24(5):374-92.

Shah AA, Wigley FM. Often forgotten manifestations of systemic sclerosis. Rheum Dis Clin North Am. 2008 Feb;34(1):221-38; ix.

Henness S, Wigley FM. Current drug therapy for scleroderma and secondary Raynaud’s phenomenon: evidence-based review”. Curr Opin Rheumatol. 2007 Nov:19(6):611-8.

Herrick A. Diagnosis and management of scleroderma peripheral vascular disease. Rheum Dis Clin North Am. 2008 Feb; 34(1):89-114; vii.

Ostojic, P. Interstitial Lung Disease in Systemic Sclerosis. Lung. 2007 Jul-Aug;185(4):211-220.

Sjogren’s Syndrome

Fox RI. Sjögren's syndrome. Lancet. 2005 Jul 23-29;366(9482):321-31.

Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004 Jun 28;164(12):1275-84.

Venables PJ. Management of patients presenting with Sjogren’s syndrome. Best Pract Res Clin Rheumatol. 2006 Aug;20(4):791-807.

Spondyloarthropathies

Kataria RK, Brent LH. Spondyloarthropathies. Am Fam Physician. 2004 Jun 15;69(12):2853-60.

Rihl M, Klos A, Kohler L, Kuipers JG. Reactive arthritis. Best Pract Res Clin Rheumatol. 2006 Dec;20(6):1119-37.

Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007 Apr 21;369(9570):1379-90.

McVeigh CM, Cairns AP. Diagnosis and management of ankylosing spondylitis. BMJ. 2006 Sep 16;333(7568):581-5.

Turkiewicz AM, Moreland LW. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 2007 Apr;56(4):1051-66.

Goupille, Philippe. Psoriatic arthritis. Joint Bone Spine. 2005 Dec;72(6):466-70.

Kyle S. Guideline for anti-TNF-alpha therapy in psoriatic arthritis. Rheumatology (Oxford). 2005 Mar;44(3):390-7.

Systemic Lupus Erythematosus

Rahman A, Iseberg DA. Systemic lupus erythematosus. N Engl J Med. 2008 Feb 28; 358(9):929-39.

Westerweel PE, et al. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum. 2007 May;56(5):1384-96.

Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity. 2005 Nov;38(7):507-18.

Pego-Reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcomes of this rare manifestation of the disease. Rheumatology (Oxford). 2008 Oct:1498-502.

Swigris JJ, Fischer A, Gillis J, Meehan RT, Brown KK. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest 2008 Jan;133(1):271-80.

Undifferentiated Connective Tissue Disease

Mosca M, Tani C, Bombardieri, S. “A case of undifferentiated connective tissue disease: is it a distinct clinical entity?”.  Nat Clin Prac Rheum. 2008 June; 4(6): 328-332.

Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol. 2007 Dec;21(6):1011-23.

Vasculitis

Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9(2):71-92.

Schmidt WA, Gromnica-Ihle E. What is the best approach to diagnosing large-vessel vasculitis? Best Pract Res Clin Rheumatol. 2005 Apr;19(2):223-42.

Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008 Jul 19:372(9634):234-45.

Puechal X, Fiessinger JN. Thromboangiitis obliterans or Buerger’s disease: challenges for the rheumatologist. Rheumatology (Oxford).2007 Feb;46(2):192-9.

Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK. Update in the diagnosis and management of pulmonary vasculitis. Chest. 2006 Feb;129(2):452-65.

Younger DS. Vasculitis of the nervous system. Curr Opin Neurol. 2004 Jun;17(3):317-36.

Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004 Jul 1;117(1):39-50.

Roberts, Paul, et al. Henoch-Schonlein Purpura: A Review Article. S Med J. 2007 Aug; 100(8):821-824.

Tann OR, Tulloh RM, Hamilton MC. Takayasu’s disease: a review. Cardiol Young. 2008 Jun;18(3):250-9.

Stone, John. Vasculitis: A Collection of Pearls and Myths. Rheum Dis Clin N Am. 2007; 33: 691-739.

Pettigrew HD, Teuber SS, Gershwin ME. Polyarteritis nodosa. Compr Ther. 2007 Fall;33(3):144-9.

Bosch X, et al. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA. 2007 Aug 8;298(6):655-69.